Search
Find a recruiting study
7,106 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Nov 1, 2026). No sign-up needed.
Most recently updated studies · page 104 of 297
- RecruitingPhase 3
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Chiesi Farmaceutici S.p.A.
- Location
- Birmingham, AL + 6 other US sites
- Eligibility basics
- Ages 13+
- Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Arga Medtech SA
- Location
- Birmingham, AL + 17 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
Takeda
- Location
- Redwood City, CA + 12 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
MISHA Post-Market Clinical Study
Moximed
- Location
- Sonoma, CA + 3 other US sites
- Eligibility basics
- Ages 25–65
- Recruiting
The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
Thrombolex, Inc.
- Location
- Scottsdale, AZ + 22 other US sites
- Eligibility basics
- Any age listed
- Recruiting
MOTION Clinical Trial
Moximed
- Location
- Oceanside, CA + 5 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 1
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Novartis Pharmaceuticals
- Location
- Aurora, CO + 3 other US sites
- Eligibility basics
- Ages 12–60
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Birmingham, AL + 131 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 3
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Novartis Pharmaceuticals
- Location
- Los Angeles, CA + 21 other US sites
- Eligibility basics
- Ages 12–60
- RecruitingPhase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics
- Location
- Birmingham, AL + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
AbbVie
- Location
- Carmel, IN + 4 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
QED Therapeutics, a BridgeBio company
- Location
- Oakland, CA + 2 other US sites
- Eligibility basics
- Ages 0 mo–2
- Recruiting
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
FemPulse Corporation
- Location
- Beverly Hills, CA + 11 other US sites
- Eligibility basics
- Ages 21+ · Women only
- RecruitingPhase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Celgene
- Location
- New York, NY
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1/Phase 2
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
AC Immune SA
- Location
- Lady Lake, FL + 3 other US sites
- Eligibility basics
- Ages 35–85
- Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Urotronic Inc.
- Location
- Little Rock, AR + 6 other US sites
- Eligibility basics
- Ages 50+ · Men only
- RecruitingPhase 1
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury
EicOsis Human Health Inc.
- Location
- Augusta, GA
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
EicOsis Human Health Inc.
- Location
- Sacramento, CA
- Eligibility basics
- Ages 50–80
- Recruiting
MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
Health Discovery Labs
- Location
- Rochester, MN + 2 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
Clinical Outcomes Study of the Nexel Total Elbow
Zimmer Biomet
- Location
- Golden, CO + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Pfizer
- Location
- Phoenix, AZ + 30 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 2
A Phase 2 Study of CRD-4730 in CPVT
Cardurion Pharmaceuticals, Inc.
- Location
- San Francisco, CA + 4 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Encino, CA + 3 other US sites
- Eligibility basics
- Ages 18–45
Data source: daily sync of the ClinicalTrials.gov API. How we list studies